Sarah Wing-Yiu Poon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sarah Wing-Yiu Poon has a total of 79 co-authors. Here are the top co-authors by number of shared publications:
- Joanna Yuet-Ling Tung
Department of Paediatrics and Adolescent Medicine , Hong Kong Children’s Hospital , Hong Kong , China
12 shared publications Betty Wai-Man But
Department of Paediatrics , Queen Elizabeth Hospital , Kowloon , Hong Kong , China
4 shared publicationsElaine Yin-Wah Kwan
Department of Paediatrics and Adolescent Medicine , Pamela Youde Nethersole Eastern Hospital , Hong Kong , Hong Kong , China
4 shared publicationsHo-Chung Yau
Department of Paediatrics , Prince of Wales Hospital , New Territories , Hong Kong , China
4 shared publicationsMing-Kut Tay
Department of Paediatrics and Adolescent Medicine , Tseung Kwan O Hospital , New Territories , Hong Kong , China
4 shared publicationsPriscilla Wai-Chee Lo
Department of Paediatrics and Adolescent Medicine , United Christian Hospital , Kowloon , Hong Kong , China
4 shared publications
Latest Publications
- Open Access
- 19 November 2026
- Published by Wiley in Pediatric Transplantation
- Vol. 30 (11)
Overweight and Rapid Weight Gain Following Pediatric Kidney Transplantation in Chinese Children
Aim: This study aimed to descriptively characterize posttransplant weight gain trajectories, obesity prevalence, and explore factors associated with weight gain in Chinese pediatric kidney transplant recipients, a population for whom such data remain limited. Methods: We conducted a retrospective cohort study of all Chinese children who received kidney transplants in Hong Kong from 2013 to 2023. Primary outcome was BMI Z scores, assessed at baseline and serially posttransplant using local reference data. Rapid weight gain was defined by ≥ 0.5 increase in BMI Z score or ≥ 10% increase in body weight during the first‐year posttransplant. Results: Fifty‐three Chinese children (59% male; median age at transplant 13.3 years, IQR, 7.9–17.8) were analyzed and followed for 6.1 years (IQR, 2.8–8.1). Mean BMI Z score increased significantly from baseline to 1‐year posttransplant (Δ = +0.47 SD, p = 0.0001). The prevalence of overweight/obesity significantly increased from 13.2% at baseline to 30.2% at 1 year ( p = 0.05). Rapid weight gain occurred in 64.2% of patients. In exploratory analyses, family history of obesity (46.7% vs. 13.5%; p = 0.03) and overweight/obesity prior to transplant (31.3% vs. 5.4%; p = 0.02) were associated with 1‐year overweight/obesity. Cardiometabolic outcomes and kidney function were comparable between patients with or without rapid weight gain. Conclusions: Significant weight gain is common following pediatric kidney transplant. Early screening, identification, and timely intervention are keys to halt disease progression.
- 19 November 2026
- Published by Wiley in Pediatric Transplantation
- Vol. 30 (11)
Open AccessOverweight and Rapid Weight Gain Following Pediatric Kidney Transplantation in Chinese Children
Aim: This study aimed to descriptively characterize posttransplant weight gain trajectories, obesity prevalence, and explore factors associated with weight gain in Chinese pediatric kidney transplant recipients, a population for whom such data remain limited. Methods: We conducted a retrospective cohort study of all Chinese children who received kidney transplants in Hong Kong from 2013 to 2023. Primary outcome was BMI Z scores, assessed at baseline and serially posttransplant using local reference data. Rapid weight gain was defined by ≥ 0.5 increase in BMI Z score or ≥ 10% increase in body weight during the first‐year posttransplant. Results: Fifty‐three Chinese children (59% male; median age at transplant 13.3 years, IQR, 7.9–17.8) were analyzed and followed for 6.1 years (IQR, 2.8–8.1). Mean BMI Z score increased significantly from baseline to 1‐year posttransplant (Δ = +0.47 SD, p = 0.0001). The prevalence of overweight/obesity significantly increased from 13.2% at baseline to 30.2% at 1 year ( p = 0.05). Rapid weight gain occurred in 64.2% of patients. In exploratory analyses, family history of obesity (46.7% vs. 13.5%; p = 0.03) and overweight/obesity prior to transplant (31.3% vs. 5.4%; p = 0.02) were associated with 1‐year overweight/obesity. Cardiometabolic outcomes and kidney function were comparable between patients with or without rapid weight gain. Conclusions: Significant weight gain is common following pediatric kidney transplant. Early screening, identification, and timely intervention are keys to halt disease progression.
- 4 November 2026
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
Clinical characteristics of paediatric-onset type 2 diabetes: a comparison by weight status in the Hong Kong childhood diabetes registry 2008 to 2023
Objectives: Although obesity is a major risk factor for paediatric type 2 diabetes (T2DM), many Asian youths present without obesity. This phenotype remains under-recognised and poorly described. This study aimed to compare the clinical and metabolic characteristics of children newly diagnosed with T2DM, stratified by weight status, in Hong Kong. Methods: We conducted a retrospective cross-sectional study using data from the Hong Kong Childhood Diabetes Registry (2008–2023). We compared the clinical and metabolic features of children with and without obesity who were newly diagnosed with T2DM. Results: A total of 689 children (96 % Chinese) were included and 35 % were children without obesity. While age at diagnosis was similar between groups, children without obesity exhibited a higher prevalence of family history of T2DM (80.6 % vs. 67.5 %; p1c and blood glucose levels at diagnosis, with lower HOMA-%B, suggesting greater β-cell dysfunction. Conversely children with obesity had higher insulin resistance. They also had higher prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD), hypertension, hyperuricaemia, obstructive sleep apnoea, and polyendocrine metabolic ovarian syndrome (PMOS). Insulin therapy was more frequently required at diagnosis in children without obesity (16.3 % vs. 8 %, p=0.001). Conclusions: These results highlight a distinct T2DM phenotype in Chinese children without obesity, marked by severe hyperglycaemia and a higher rate of insulin requirement at diagnosis. Increased clinical vigilance for this under-recognised group is warranted to optimise management at diagnosis, with long term outcomes to be address in future longitudinal studies.
- 4 November 2026
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
Clinical characteristics of paediatric-onset type 2 diabetes: a comparison by weight status in the Hong Kong childhood diabetes registry 2008 to 2023
Objectives: Although obesity is a major risk factor for paediatric type 2 diabetes (T2DM), many Asian youths present without obesity. This phenotype remains under-recognised and poorly described. This study aimed to compare the clinical and metabolic characteristics of children newly diagnosed with T2DM, stratified by weight status, in Hong Kong. Methods: We conducted a retrospective cross-sectional study using data from the Hong Kong Childhood Diabetes Registry (2008–2023). We compared the clinical and metabolic features of children with and without obesity who were newly diagnosed with T2DM. Results: A total of 689 children (96 % Chinese) were included and 35 % were children without obesity. While age at diagnosis was similar between groups, children without obesity exhibited a higher prevalence of family history of T2DM (80.6 % vs. 67.5 %; p1c and blood glucose levels at diagnosis, with lower HOMA-%B, suggesting greater β-cell dysfunction. Conversely children with obesity had higher insulin resistance. They also had higher prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD), hypertension, hyperuricaemia, obstructive sleep apnoea, and polyendocrine metabolic ovarian syndrome (PMOS). Insulin therapy was more frequently required at diagnosis in children without obesity (16.3 % vs. 8 %, p=0.001). Conclusions: These results highlight a distinct T2DM phenotype in Chinese children without obesity, marked by severe hyperglycaemia and a higher rate of insulin requirement at diagnosis. Increased clinical vigilance for this under-recognised group is warranted to optimise management at diagnosis, with long term outcomes to be address in future longitudinal studies.
- Open Access
- 30 June 2026
- Published by Korean Society of Pediatric Endocrinology in Annals of Pediatric Endocrinology & Metabolism
- Vol. 31 (3) , 168-177
Long-term outcomes in 45,X/46,XY mosaicism: a 30-year retrospective study in Hong Kong
Purpose: 45,X/46,XY mosaicism is a rare subset of sex chromosome abnormalities within the spectrum of differences of sex development. This study aimed to evaluate the long-term outcomes in a group of individuals with 45,X/46,XY mosaicism over a 30-year period.Methods: A retrospective review was performed including 68 patients diagnosed from January 1990 to December 2023 at a tertiary unit. Cytogenetic analysis, patient demographics and various health outcomes were examined.Results: Thirty-five patients were raised as females and 33 were raised as males. Fifteen patients were found to have 45,X/46,XY mosaicism prenatally. The prevalence of gonadal tumor was 17.6% among phenotypic females and 38.5% in males with abnormal genitalia, whereas no tumors were detected in males with normal genitalia. The mean external genitalia score was significantly lower in males with gonadal tumors compared to those without (6.6 vs 10.4, P=0.002). For females, while most gonadal tumors were identified in those who had gonadectomy at pubertal age (5 of 6, 83.3%), gonadal tumors were also detected in very young children (1.3 years old). There was no significant improvement in height in those treated with growth hormone therapy and final adult height remained suboptimal (overall final adult height z-score -2.6±1.2). Adherence to surveillance for associated systemic comorbidities was inconsistent.Conclusion: Gonadal tumor risk is higher in less masculinized males, while females may develop tumors across a wide age range. The long-term efficacy of growth hormone therapy in these patients remains unclear. Our findings emphasized the need for individualized surveillance in this population.
- 30 June 2026
- Published by Korean Society of Pediatric Endocrinology in Annals of Pediatric Endocrinology & Metabolism
- Vol. 31 (3) , 168-177
Open AccessLong-term outcomes in 45,X/46,XY mosaicism: a 30-year retrospective study in Hong Kong
Purpose: 45,X/46,XY mosaicism is a rare subset of sex chromosome abnormalities within the spectrum of differences of sex development. This study aimed to evaluate the long-term outcomes in a group of individuals with 45,X/46,XY mosaicism over a 30-year period.Methods: A retrospective review was performed including 68 patients diagnosed from January 1990 to December 2023 at a tertiary unit. Cytogenetic analysis, patient demographics and various health outcomes were examined.Results: Thirty-five patients were raised as females and 33 were raised as males. Fifteen patients were found to have 45,X/46,XY mosaicism prenatally. The prevalence of gonadal tumor was 17.6% among phenotypic females and 38.5% in males with abnormal genitalia, whereas no tumors were detected in males with normal genitalia. The mean external genitalia score was significantly lower in males with gonadal tumors compared to those without (6.6 vs 10.4, P=0.002). For females, while most gonadal tumors were identified in those who had gonadectomy at pubertal age (5 of 6, 83.3%), gonadal tumors were also detected in very young children (1.3 years old). There was no significant improvement in height in those treated with growth hormone therapy and final adult height remained suboptimal (overall final adult height z-score -2.6±1.2). Adherence to surveillance for associated systemic comorbidities was inconsistent.Conclusion: Gonadal tumor risk is higher in less masculinized males, while females may develop tumors across a wide age range. The long-term efficacy of growth hormone therapy in these patients remains unclear. Our findings emphasized the need for individualized surveillance in this population.
- Open Access
- 28 February 2026
- Published by Korean Society of Pediatric Endocrinology in Annals of Pediatric Endocrinology & Metabolism
- Vol. 31 (1) , 20-29
High prevalence of metabolic comorbidities in Asian children with type 1 diabetes and obesity
Purpose: This study aims to examine the prevalence of overweight and obesity in children with type 1 diabetes mellitus (T1DM) in Hong Kong and to evaluate the association between obesity, glycemic control, and metabolic comorbidities.Methods: A retrospective cross-sectional study was conducted from 2022–2023 at the Hong Kong Children’s Hospital, enrolling all children with T1DM. Anthropometric measurements and biochemical data were extracted from medical records, and prevalence rates of metabolic complications were compared.Results: One hundred twenty-six children (41% male, 89% Asian) with a median age of 12.8 years were included. Of these, 17.5% were either overweight or obese. There were no significant differences in hemoglobin A1c values between the normal-weight and overweight/obesity groups, though the latter group required higher total daily insulin doses. Children with overweight/obesity had higher prevalence rates of hypertension (28.6% vs. 2.9%) and dyslipidemia (90.5% vs. 71.9%). They were also more likely to have hypertension (adjusted odds ratio [aOR], 18.48; 95% confidence interval [CI], 3.42–99.94) and hypertriglyceridemia (aOR, 7.71; 95% CI, 1.66–35.76). The overweight/obese group also exhibited significantly higher alanine aminotransferase levels (median, 18 IU/L vs. 14 IU/L), non–high-density lipoprotein cholesterol (HDL-C) levels (median, 3.3 mmol/L vs. 2.9 mmol/L), and triglyceride/HDL-C ratios (median, 1.09 vs. 0.52) and lower HDL-C levels (median, 1.4 mmol/L vs. 1.6 mmol/L). Among those with dyslipidemia, only 8% were started on lipid-lowering agents, while none of those with hypertension were started on antihypertensive agents.Conclusion: Despite a lower prevalence of overweight/obesity in Asian children with T1DM compared to Western populations, metabolic comorbidities occur at an exceptionally high rate. Early interventions to tackle these modifiable cardiovascular risk factors are crucial to prevent long-term complications.
- 28 February 2026
- Published by Korean Society of Pediatric Endocrinology in Annals of Pediatric Endocrinology & Metabolism
- Vol. 31 (1) , 20-29
Open AccessHigh prevalence of metabolic comorbidities in Asian children with type 1 diabetes and obesity
Purpose: This study aims to examine the prevalence of overweight and obesity in children with type 1 diabetes mellitus (T1DM) in Hong Kong and to evaluate the association between obesity, glycemic control, and metabolic comorbidities.Methods: A retrospective cross-sectional study was conducted from 2022–2023 at the Hong Kong Children’s Hospital, enrolling all children with T1DM. Anthropometric measurements and biochemical data were extracted from medical records, and prevalence rates of metabolic complications were compared.Results: One hundred twenty-six children (41% male, 89% Asian) with a median age of 12.8 years were included. Of these, 17.5% were either overweight or obese. There were no significant differences in hemoglobin A1c values between the normal-weight and overweight/obesity groups, though the latter group required higher total daily insulin doses. Children with overweight/obesity had higher prevalence rates of hypertension (28.6% vs. 2.9%) and dyslipidemia (90.5% vs. 71.9%). They were also more likely to have hypertension (adjusted odds ratio [aOR], 18.48; 95% confidence interval [CI], 3.42–99.94) and hypertriglyceridemia (aOR, 7.71; 95% CI, 1.66–35.76). The overweight/obese group also exhibited significantly higher alanine aminotransferase levels (median, 18 IU/L vs. 14 IU/L), non–high-density lipoprotein cholesterol (HDL-C) levels (median, 3.3 mmol/L vs. 2.9 mmol/L), and triglyceride/HDL-C ratios (median, 1.09 vs. 0.52) and lower HDL-C levels (median, 1.4 mmol/L vs. 1.6 mmol/L). Among those with dyslipidemia, only 8% were started on lipid-lowering agents, while none of those with hypertension were started on antihypertensive agents.Conclusion: Despite a lower prevalence of overweight/obesity in Asian children with T1DM compared to Western populations, metabolic comorbidities occur at an exceptionally high rate. Early interventions to tackle these modifiable cardiovascular risk factors are crucial to prevent long-term complications.
- 19 February 2026
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 39 (3) , 251-257
Suboptimal adoption of diabetes technology despite coverage and the impact on glycemic outcomes in children and adolescents with type 1 diabetes in Hong Kong
Objectives: Despite proven benefits of diabetes technologies in children with type 1 diabetes (T1DM), utilization varies globally. In Hong Kong, continuous glucose monitoring system (CGMS) uptake was low (10.6 %) in 2018; however reimbursement programs have been implemented since then to enhance accessibility. This study examined trends in diabetes technology adoption and glycemic outcomes from 2018 to 2023. Methods: The Hong Kong Childhood Diabetes Registry prospectively collected standardized data on all children with diabetes at age ≤18 years in public hospitals since 2018, and those with follow-up data between 2018 and 2023 were included. Regular CGMS use was defined as >80 % usage/year. Outcomes included mean HbA 1c levels, incidence of diabetic ketoacidosis (DKA) and severe hypoglycemia. Clinical and psychosocial factors were compared between regular and non-regular CGMS users. Results: Mean HbA 1c significantly decreased from 8.3 % in 2018 to 8.0 % in 2023 (p9 % and a reduced rate of DKA. Regular CGMS use increased from 10.7 to 41.7 %, with highest adoption among school-aged children and lowest among adolescents. Compared to non-regular users, regular CGMS users demonstrated better glycemic outcome (mean HbA 1c 7.6 vs. 8.2 %, p<0.05). There were no significant differences in rates of micro/macrovascular complications or severe hypoglycemic events between the two groups. Conclusions: Despite improved glycemic outcomes and free access, CGMS adoption remained suboptimal in Hong Kong particularly among adolescents, indicating barriers beyond cost. Further research is needed to identify these barriers and develop targeted strategies to enhance technology use.
- 19 February 2026
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 39 (3) , 251-257
Suboptimal adoption of diabetes technology despite coverage and the impact on glycemic outcomes in children and adolescents with type 1 diabetes in Hong Kong
Objectives: Despite proven benefits of diabetes technologies in children with type 1 diabetes (T1DM), utilization varies globally. In Hong Kong, continuous glucose monitoring system (CGMS) uptake was low (10.6 %) in 2018; however reimbursement programs have been implemented since then to enhance accessibility. This study examined trends in diabetes technology adoption and glycemic outcomes from 2018 to 2023. Methods: The Hong Kong Childhood Diabetes Registry prospectively collected standardized data on all children with diabetes at age ≤18 years in public hospitals since 2018, and those with follow-up data between 2018 and 2023 were included. Regular CGMS use was defined as >80 % usage/year. Outcomes included mean HbA 1c levels, incidence of diabetic ketoacidosis (DKA) and severe hypoglycemia. Clinical and psychosocial factors were compared between regular and non-regular CGMS users. Results: Mean HbA 1c significantly decreased from 8.3 % in 2018 to 8.0 % in 2023 (p9 % and a reduced rate of DKA. Regular CGMS use increased from 10.7 to 41.7 %, with highest adoption among school-aged children and lowest among adolescents. Compared to non-regular users, regular CGMS users demonstrated better glycemic outcome (mean HbA 1c 7.6 vs. 8.2 %, p<0.05). There were no significant differences in rates of micro/macrovascular complications or severe hypoglycemic events between the two groups. Conclusions: Despite improved glycemic outcomes and free access, CGMS adoption remained suboptimal in Hong Kong particularly among adolescents, indicating barriers beyond cost. Further research is needed to identify these barriers and develop targeted strategies to enhance technology use.
- 11 October 2025
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 73 (1) , e32098
Evaluating Diagnostic Delays and Late Endocrine Sequelae in Children With Intracranial Germ Cell Tumors: A Territory‐Wide Population‐Based Study
Background: Intracranial germ cell tumors (ICGCTs) represent a rare subset of neoplasms with notably higher incidence in Asian cohorts compared to Western counterparts. Diagnostic delays in ICGCT, frequently associated with endocrine presentations, have previously been documented. However, factors contributing to delays, as well as the implications for clinical outcomes, remain insufficiently elucidated. This study aims to evaluate presentations, diagnostic intervals, and long‐term endocrine sequelae in children with ICGCT. Methods: This retrospective cohort study included all children diagnosed with ICGCT from 2008 to 2023 in Hong Kong. Clinical, pathological, and endocrine data were collected with treatment outcomes and survival analyzed. Prolonged diagnostic interval was defined as > 6 months from symptom onset. Results: A total of 104 children with ICGCT (59.6% males, median age 12.6 years, follow‐up 6.8 years) were included. About 64.4% had germinoma. Endocrine deficits were present in 63.5% at diagnosis. The median diagnostic interval was 3 months. About 32.7% had prolonged diagnostic intervals, particularly for suprasellar tumors and those presenting with endocrinopathies. Inconclusive MRI, as well as caveats in tumor biopsy, also contributed to delayed diagnosis. Diagnostic interval had no impact on overall survival and progression‐free survival, but children with diagnostic delay tend to be shorter. At follow‐up, 66.3% had persistent endocrinopathies, in addition to 40.8% being overweight/obese and 60% having low bone mineral density. Conclusion: Our study highlighted patient‐related, physician‐related, and tumor‐related delays in the diagnosis of pediatric ICGCT. Although there was no impact on mortality, children with diagnostic delay tend to be shorter. Surveillance of endocrinopathies alongside assessment of weight status and bone health is essential.
- 11 October 2025
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 73 (1) , e32098
Evaluating Diagnostic Delays and Late Endocrine Sequelae in Children With Intracranial Germ Cell Tumors: A Territory‐Wide Population‐Based Study
Background: Intracranial germ cell tumors (ICGCTs) represent a rare subset of neoplasms with notably higher incidence in Asian cohorts compared to Western counterparts. Diagnostic delays in ICGCT, frequently associated with endocrine presentations, have previously been documented. However, factors contributing to delays, as well as the implications for clinical outcomes, remain insufficiently elucidated. This study aims to evaluate presentations, diagnostic intervals, and long‐term endocrine sequelae in children with ICGCT. Methods: This retrospective cohort study included all children diagnosed with ICGCT from 2008 to 2023 in Hong Kong. Clinical, pathological, and endocrine data were collected with treatment outcomes and survival analyzed. Prolonged diagnostic interval was defined as > 6 months from symptom onset. Results: A total of 104 children with ICGCT (59.6% males, median age 12.6 years, follow‐up 6.8 years) were included. About 64.4% had germinoma. Endocrine deficits were present in 63.5% at diagnosis. The median diagnostic interval was 3 months. About 32.7% had prolonged diagnostic intervals, particularly for suprasellar tumors and those presenting with endocrinopathies. Inconclusive MRI, as well as caveats in tumor biopsy, also contributed to delayed diagnosis. Diagnostic interval had no impact on overall survival and progression‐free survival, but children with diagnostic delay tend to be shorter. At follow‐up, 66.3% had persistent endocrinopathies, in addition to 40.8% being overweight/obese and 60% having low bone mineral density. Conclusion: Our study highlighted patient‐related, physician‐related, and tumor‐related delays in the diagnosis of pediatric ICGCT. Although there was no impact on mortality, children with diagnostic delay tend to be shorter. Surveillance of endocrinopathies alongside assessment of weight status and bone health is essential.
- 21 December 2023
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 37 (2) , 130-136
Review on the screening of urine glucose for early diagnosis of type 2 diabetes mellitus in school children and adolescents with obesity in Hong Kong
Objectives Obesity and type 2 diabetes mellitus (T2DM) are growing health concerns. Since 2005, Student Health Service (SHS) and Hong Kong Paediatric Society formulated a protocol on urine glucose screening (UGS) for early diagnosis of T2DM in students with obesity in Hong Kong. This study reviews students with T2DM captured by this screening program and compare the data with the Hong Kong Children Diabetes Registry (HKCDR) database, to see if the UGS program facilitates early diagnosis of T2DM. Methods Students between the ages of 10–18 years old with age- and sex-specific body mass index (BMI) >97th percentile who attended SHS between the school years from 2005/06 to 2017/18 were recruited for UGS. Those tested positive for random urine glucose underwent diagnostic testing for T2DM according to ADA guidelines. Demographic data and investigatory results from UGS and HKCDR within the same time period were compared. Results 216,526 students completed UGS in the said period; 415 (0.19 %) students were tested positive for urine glucose of which 121 students were diagnosed with T2DM. UGS picked up 23 % of the newly diagnosed T2DM cases. When compared to the HKCDR database, students diagnosed via UGS were significantly younger, less obese, and had fewer diabetic related complications. The negative predictive value of UGS is high and can effectively rule out T2DM. Conclusions Urine glucose screening is an inexpensive and simple test that allows for early diagnosis of T2DM among obese school students. Other methods including POCT HbA1c can be explored to improve program effectiveness.
- 21 December 2023
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 37 (2) , 130-136
Review on the screening of urine glucose for early diagnosis of type 2 diabetes mellitus in school children and adolescents with obesity in Hong Kong
Objectives Obesity and type 2 diabetes mellitus (T2DM) are growing health concerns. Since 2005, Student Health Service (SHS) and Hong Kong Paediatric Society formulated a protocol on urine glucose screening (UGS) for early diagnosis of T2DM in students with obesity in Hong Kong. This study reviews students with T2DM captured by this screening program and compare the data with the Hong Kong Children Diabetes Registry (HKCDR) database, to see if the UGS program facilitates early diagnosis of T2DM. Methods Students between the ages of 10–18 years old with age- and sex-specific body mass index (BMI) >97th percentile who attended SHS between the school years from 2005/06 to 2017/18 were recruited for UGS. Those tested positive for random urine glucose underwent diagnostic testing for T2DM according to ADA guidelines. Demographic data and investigatory results from UGS and HKCDR within the same time period were compared. Results 216,526 students completed UGS in the said period; 415 (0.19 %) students were tested positive for urine glucose of which 121 students were diagnosed with T2DM. UGS picked up 23 % of the newly diagnosed T2DM cases. When compared to the HKCDR database, students diagnosed via UGS were significantly younger, less obese, and had fewer diabetic related complications. The negative predictive value of UGS is high and can effectively rule out T2DM. Conclusions Urine glucose screening is an inexpensive and simple test that allows for early diagnosis of T2DM among obese school students. Other methods including POCT HbA1c can be explored to improve program effectiveness.
- Open Access
- 8 May 2023
- Published by The Endocrine Society in JCEM Case Reports
- Vol. 1 (3) , luad044
Two Girls With Adrenal Insufficiency and Failing Gonads
Congenital lipoid adrenal hyperplasia (CLAH) is a rare cause of adrenal insufficiency caused by mutations in the steroidogenic acute regulatory (StAR) gene. Patients classically present with adrenal crisis in early infancy and female external genitalia irrespective of chromosomal sex. We report 2 Chinese patients with normal female external genitalia presenting with salt wasting in the neonatal period. However, the diagnosis of CLAH was made only during pubertal years when they developed hypergonadotropic hypogonadism. One of them was subsequently found to have a 46XY karyotype and gonadectomy was performed at age 15 years. The other patient developed gonadal insufficiency and polycystic ovaries after menarche with hemorrhage into ovarian cysts requiring cystectomy. These 2 cases illustrate the importance of recognizing atypical features in neonates presenting with adrenal crisis. In managing the newborn with adrenal insufficiency and female-appearing external genitalia, the possibility of sex reversal and diagnosis of CLAH should be considered. Accurate delineation of internal pelvic organs using reliable imaging modalities or even laparoscopy, together with careful interpretation of clinical and laboratory findings, are crucial to accurate diagnosis and subsequent management.
- 8 May 2023
- Published by The Endocrine Society in JCEM Case Reports
- Vol. 1 (3) , luad044
Open AccessTwo Girls With Adrenal Insufficiency and Failing Gonads
Congenital lipoid adrenal hyperplasia (CLAH) is a rare cause of adrenal insufficiency caused by mutations in the steroidogenic acute regulatory (StAR) gene. Patients classically present with adrenal crisis in early infancy and female external genitalia irrespective of chromosomal sex. We report 2 Chinese patients with normal female external genitalia presenting with salt wasting in the neonatal period. However, the diagnosis of CLAH was made only during pubertal years when they developed hypergonadotropic hypogonadism. One of them was subsequently found to have a 46XY karyotype and gonadectomy was performed at age 15 years. The other patient developed gonadal insufficiency and polycystic ovaries after menarche with hemorrhage into ovarian cysts requiring cystectomy. These 2 cases illustrate the importance of recognizing atypical features in neonates presenting with adrenal crisis. In managing the newborn with adrenal insufficiency and female-appearing external genitalia, the possibility of sex reversal and diagnosis of CLAH should be considered. Accurate delineation of internal pelvic organs using reliable imaging modalities or even laparoscopy, together with careful interpretation of clinical and laboratory findings, are crucial to accurate diagnosis and subsequent management.
- Open Access
- 19 April 2023
- Published by Galenos Yayinevi in Journal of Clinical Research in Pediatric Endocrinology
- Vol. 17 (1) , 115-119
Diazoxide-unresponsive Hyperinsulinemic Hypoglycaemia in a Preterm Infant with Heterozygous Insulin Receptor Gene Mutation
Homozygous or compound heterozygous mutations in insulin receptor gene (INSR) lead to marked insulin resistance and hyperglycaemia in Donohue syndrome and Rabson-Mendenhall syndrome, conditions which are associated with significant morbidity early in life. On the other hand, heterozygous INSR gene mutations result in milder phenotype known as type A insulin resistance syndrome. While presentation in adults with this condition is well reported, phenotypes in infant are less well-characterized. We herein report an infant presenting with hyperinsulinemic hypoglycaemia who did not respond to diazoxide therapy. She was subsequently found to carry heterozygous INSR gene mutation. Our patient was a female infant born at 29 weeks of gestation who developed recurrent hypoglycaemia in early infancy. Workup showed hyperinsulinism and she was started on first-line therapy with diazoxide and high-calorie feeds. However, continuous blood glucose monitoring showed post-prandial hyperglycaemia followed by rapid fall to hypogylcaemia. Whole exome sequencing was performed to investigate for diazoxide-unresponsive hyperinsulinism, which revealed a likely pathogenic mutation in the INSR gene c.1246C>T p. (R416X). This nonsense mutation was inherited from the father. With the molecular diagnosis, diazoxide was stopped and she followed a diet with low glycaemic-index food. Subsequent monitoring showed stable glucose profile. Our case highlights the importance to consider type A insulin resistance syndrome when no mutation could be identified in the ABCC8/KCNJ11 genes in diazoxide-unresponsive hyperinsulinism. With autosomal dominant inheritance, cascade screening should be performed in family members to identify those harbouring the mutation as they are at risk of early onset diabetes.
- 19 April 2023
- Published by Galenos Yayinevi in Journal of Clinical Research in Pediatric Endocrinology
- Vol. 17 (1) , 115-119
Open AccessDiazoxide-unresponsive Hyperinsulinemic Hypoglycaemia in a Preterm Infant with Heterozygous Insulin Receptor Gene Mutation
Homozygous or compound heterozygous mutations in insulin receptor gene (INSR) lead to marked insulin resistance and hyperglycaemia in Donohue syndrome and Rabson-Mendenhall syndrome, conditions which are associated with significant morbidity early in life. On the other hand, heterozygous INSR gene mutations result in milder phenotype known as type A insulin resistance syndrome. While presentation in adults with this condition is well reported, phenotypes in infant are less well-characterized. We herein report an infant presenting with hyperinsulinemic hypoglycaemia who did not respond to diazoxide therapy. She was subsequently found to carry heterozygous INSR gene mutation. Our patient was a female infant born at 29 weeks of gestation who developed recurrent hypoglycaemia in early infancy. Workup showed hyperinsulinism and she was started on first-line therapy with diazoxide and high-calorie feeds. However, continuous blood glucose monitoring showed post-prandial hyperglycaemia followed by rapid fall to hypogylcaemia. Whole exome sequencing was performed to investigate for diazoxide-unresponsive hyperinsulinism, which revealed a likely pathogenic mutation in the INSR gene c.1246C>T p. (R416X). This nonsense mutation was inherited from the father. With the molecular diagnosis, diazoxide was stopped and she followed a diet with low glycaemic-index food. Subsequent monitoring showed stable glucose profile. Our case highlights the importance to consider type A insulin resistance syndrome when no mutation could be identified in the ABCC8/KCNJ11 genes in diazoxide-unresponsive hyperinsulinism. With autosomal dominant inheritance, cascade screening should be performed in family members to identify those harbouring the mutation as they are at risk of early onset diabetes.
- Open Access
- 24 August 2022
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 35 (9) , 1132-1140
Diabetic ketoacidosis in children with new-onset type 1 diabetes mellitus: demographics, risk factors and outcome: an 11 year review in Hong Kong
Objectives Diabetic ketoacidosis (DKA) is a life-threatening complication of type 1 diabetes (T1D). The aim of this study is to analyze the incidence, clinical characteristics, management and outcome of children presenting with DKA in new-onset T1D from 2008 to 2018 in Hong Kong. Methods Data was extracted from the Hong Kong Childhood Diabetes Registry. All subjects less than 18 years with newly diagnosed T1D from 1 January 2008 to 31 December 2018 managed in the public hospitals were included. Information on demographics, laboratory parameters, DKA-related complications and management were analyzed. Results In the study period, there were 556 children with newly diagnosed T1D in our registry and 43.3% presented with DKA. The crude incidence rate of new-onset T1D with DKA was 1.79 per 100,000 persons/year (CI: 1.56–2.04). Subjects presenting with DKA were younger (9.5 ± 4.5 vs. 10.5 ± 4.4, p=0.01) and had shorter duration of symptoms (4.2 ± 5.9 days vs. 10.6 ± 17.1 days, p<0.01). Regarding management, up to 12.4% were given insulin boluses and 82.6% were started on insulin infusion 1 h after fluid resuscitation. The rate of cerebral edema was 0.8% and there was no mortality. Conclusions Younger age and shorter duration of symptoms were associated with DKA in new-onset T1D. Despite availability of international guidelines, there was inconsistency in acute DKA management. These call for a need to raise public awareness on childhood diabetes as well as standardization of practice in management of pediatric DKA in Hong Kong.
- 24 August 2022
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 35 (9) , 1132-1140
Open AccessDiabetic ketoacidosis in children with new-onset type 1 diabetes mellitus: demographics, risk factors and outcome: an 11 year review in Hong Kong
Objectives Diabetic ketoacidosis (DKA) is a life-threatening complication of type 1 diabetes (T1D). The aim of this study is to analyze the incidence, clinical characteristics, management and outcome of children presenting with DKA in new-onset T1D from 2008 to 2018 in Hong Kong. Methods Data was extracted from the Hong Kong Childhood Diabetes Registry. All subjects less than 18 years with newly diagnosed T1D from 1 January 2008 to 31 December 2018 managed in the public hospitals were included. Information on demographics, laboratory parameters, DKA-related complications and management were analyzed. Results In the study period, there were 556 children with newly diagnosed T1D in our registry and 43.3% presented with DKA. The crude incidence rate of new-onset T1D with DKA was 1.79 per 100,000 persons/year (CI: 1.56–2.04). Subjects presenting with DKA were younger (9.5 ± 4.5 vs. 10.5 ± 4.4, p=0.01) and had shorter duration of symptoms (4.2 ± 5.9 days vs. 10.6 ± 17.1 days, p<0.01). Regarding management, up to 12.4% were given insulin boluses and 82.6% were started on insulin infusion 1 h after fluid resuscitation. The rate of cerebral edema was 0.8% and there was no mortality. Conclusions Younger age and shorter duration of symptoms were associated with DKA in new-onset T1D. Despite availability of international guidelines, there was inconsistency in acute DKA management. These call for a need to raise public awareness on childhood diabetes as well as standardization of practice in management of pediatric DKA in Hong Kong.